YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Company Logo Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Gene Transfer Technologies Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been added to ResearchAndMarkets.com's offering.…
Company Logo Europe's cell therapy sector is shifting to closed, automated systems, creating opportunities in AI monitoring, modular scale-up, CAR-T/ATMP production and decentralized manufacturing Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) --…
This article first appeared on GuruFocus. Revenue: CHF3.4 billion, with a CER sales growth of 16% compared to H1 2025. Core EBITDA: CHF1.2 billion, representing a margin of 34.8%, an increase of 4.4 percentage points versus H1 2025. Free C…
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Lonza Group Ag (LZAGY). But which of these two stocks is more attractive to value investors? We'll need to tak…
LONDON, July 8, 2026 /PRNewswire/ -- Persistence Market Research, a leading management consulting firm, has released this update on the cell culture media market. These specialized nutrient formulations provide the essential environment fo…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Bioprocess Digital Twin Market size & share revenue was valued at approximately USD 0.…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Stem Cell Culture Media Market size & share revenue was valued at approximately USD 76…
NEWARK, Del., May 19, 2026 /PRNewswire/ -- According to the latest market analysis by Future Market Insights (FMI), the global Cell Culture Media Market is projected to grow from USD 3.7 billion in 2026 to USD 7.1 billion by 2036, expandin…
Company Logo Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., and Patheon Pharma Services Lead the Industry Oral Solid Dosage Contract Manufacturing MarketOral Solid Dosage Contract Manufacturing Ma…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Cell Culture Media Bags Market size & share revenue was valued at approximately USD 1.…
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Wondering whether Lonza Group at about CHF 508 per share still makes sense for your portfolio, or i…
Mechanistic modeling approach and experimental integration designed to improve early risk identification, strengthen regulatory confidence, and expand AI-enabled workflows connecting data to decision-making RESEARCH TRIANGLE PARK, N.C., Ap…
Company Logo With a focus on specialty medicines, growth is driven by pharmaceutical needs for cost-effective, efficient production and regulatory compliance via CDMOs Small Molecule Innovator API CDMO MarketSmall Molecule Innovator API CD…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Viral Vaccine Cell Culture Media Market size & share revenue was valued at approximat…
DALLAS & NEW YORK & LONDON & TOKYO, March 06, 2026--(BUSINESS WIRE)--Lone Star Funds ("Lone Star") today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingre…
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. Active investors aim to buy stocks that vastly outperform the market - but in the process, they risk under-performance. Investors…
This article first appeared on GuruFocus. Revenue: CHF 6.5 billion in 2025, a growth of 21.7% in constant currency. Vacaville Site Contribution: CHF 0.6 billion in sales. CORE EBITDA Margin: 31.6%, up 1.4 percentage points from the previou…
Company Logo Features Profiles of Key Players Bio-Techne, bioMerieux, Roche, Lonza Group, Miltenyi Biotec India and More Cell and Gene Therapy Manufacturing QC MarketCell and Gene Therapy Manufacturing QC Market·GlobeNewswire Inc. Dublin,…
Key Insights Lonza Group's estimated fair value is CHF412 based on 2 Stage Free Cash Flow to Equity Lonza Group is estimated to be 34% overvalued based on current share price of CHF554 The CHF677 analyst price target for LONN is 64% more t…
Multi-target license agreement grants Sidewinder access to Lonza's clinically validated ADC platform Sidewinder's pipeline of precision bispecific ADCs combined with Lonza's clinically validated ADC platform will enable the development of…
FORT LAUDERDALE, Fla., Jan. 6, 2026 /PRNewswire/ -- GBI Biomanufacturing, a U.S.-based biopharmaceutical CDMO providing integrated development and cGMP manufacturing services for complex biologics, today announced that Jesse McCool, Ph.D.…
Most readers would already be aware that Lonza Group's (VTX:LONN) stock increased significantly by 8.8% over the past month. However, we decided to pay attention to the company's fundamentals which don't appear to give a clear sign about t…
Investing.com - Shares of Lonza spiked in early European trading on Thursday after the Swiss contract pharmaceutical firm confirmed a "significant" long-term commercial supply agreement at one of the world’s largest manufacturing sites for…
Lonza Group AG (VTX:LONN) saw significant share price movement during recent months on the SWX, rising to highs of CHF580 and falling to the lows of CHF518. Some share price movements can give investors a better opportunity to enter into t…
Investors interested in stocks from the Medical - Products sector have probably already heard of Royal Philips (PHG) and Lonza Group Ag (LZAGY). But which of these two stocks offers value investors a better bang for their buck right now? W…
[Many different pills on pink background. Prescription pills and vitamins. Flat lay and space for text.] Baurzhan Ibrashev European and Asian pharmaceutical stocks fell Friday after President Donald Trump unveiled sweeping new tariffs, inc…
License agreement centered around technology enabling dual-payload ADC Unique combination of Synaffix's exatecan-based technology with Qurient's CDK7 inhibitor AMSTERDAM and SEONGNAM-SI, South Korea , Sept. 25, 2025 /PRNewswire/ -- Synaffi…
The price trend for Lonza Group Ag (LZAGY) has been bearish lately and the stock has lost 5.4% over the past two weeks. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a t…
Key Insights Lonza Group's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public 38% of the business is held by the top 25 shareholders Institutions own 50% of Lonz…
By buying an index fund, investors can approximate the average market return. But if you choose individual stocks with prowess, you can make superior returns. For example, the Lonza Group AG (VTX:LONN) share price is up 10% in the last thr…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Chemical Reagents Market size & share revenue was valued at approximately USD 14.1 Bi…
Company Logo The Mexico Microcarrier Market is poised for significant growth, projected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, achieving a CAGR of 7.66% from 2025 to 2033. Key drivers include increased investmen…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Arabinogalactan Market size & share revenue was valued at approximately USD 201 Milli…
The subdued stock price reaction suggests that Lonza Group AG's (VTX:LONN) strong earnings didn't offer any surprises. Our analysis suggests that investors might be missing some promising details. We've found 21 US stocks that are forecast…
Lonza Group (VTX:LONN) First Half 2025 Results Key Financial Results Revenue: CHF3.58b (up 17% from 1H 2024). Net income: CHF426.0m (up 30% from 1H 2024). Profit margin: 12% (up from 11% in 1H 2024). EPS: CHF6.08 (up from CHF4.61 in 1H 202…
Company Logo The Europe Pyridine Market is set to grow from USD 198.85 million in 2024 to USD 288.21 million by 2033, at a CAGR of 4.21%. This growth is driven by rising demand in agrochemicals, pharmaceuticals, and food industries. Pyridi…